DexCom EBITDA 2010-2025 | DXCM
DexCom annual and quarterly EBITDA history from 2010 to 2025. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
- DexCom EBITDA for the quarter ending June 30, 2025 was $0.276B, a 31.18% increase year-over-year.
- DexCom EBITDA for the twelve months ending June 30, 2025 was $0.923B, a 4.12% increase year-over-year.
- DexCom 2024 annual EBITDA was $0.818B, a 4.34% increase from 2023.
- DexCom 2023 annual EBITDA was $0.784B, a 43.25% increase from 2022.
- DexCom 2022 annual EBITDA was $0.547B, a 48.75% increase from 2021.
| DexCom Annual EBITDA (Millions of US $) |
|
|---|---|
| 2024 | $818 |
| 2023 | $784 |
| 2022 | $547 |
| 2021 | $368 |
| 2020 | $367 |
| 2019 | $191 |
| 2018 | $-157 |
| 2017 | $-26 |
| 2016 | $-49 |
| 2015 | $-46 |
| 2014 | $-13 |
| 2013 | $-21 |
| 2012 | $-48 |
| 2011 | $-40 |
| 2010 | $-42 |
| 2009 | $-42 |
| DexCom Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2025-06-30 | $276 |
| 2025-03-31 | $194 |
| 2024-12-31 | $247 |
| 2024-09-30 | $207 |
| 2024-06-30 | $210 |
| 2024-03-31 | $154 |
| 2023-12-31 | $269 |
| 2023-09-30 | $254 |
| 2023-06-30 | $172 |
| 2023-03-31 | $89 |
| 2022-12-31 | $162 |
| 2022-09-30 | $187 |
| 2022-06-30 | $121 |
| 2022-03-31 | $78 |
| 2021-12-31 | $33 |
| 2021-09-30 | $144 |
| 2021-06-30 | $125 |
| 2021-03-31 | $67 |
| 2020-12-31 | $124 |
| 2020-09-30 | $113 |
| 2020-06-30 | $83 |
| 2020-03-31 | $47 |
| 2019-12-31 | $116 |
| 2019-09-30 | $69 |
| 2019-06-30 | $11 |
| 2019-03-31 | $-5 |
| 2018-12-31 | $-156 |
| 2018-09-30 | $22 |
| 2018-06-30 | $2 |
| 2018-03-31 | $-25 |
| 2017-12-31 | $16 |
| 2017-09-30 | $4 |
| 2017-06-30 | $-10 |
| 2017-03-31 | $-37 |
| 2016-12-31 | $-3 |
| 2016-09-30 | $-14 |
| 2016-06-30 | $-16 |
| 2016-03-31 | $-16 |
| 2015-12-31 | $4 |
| 2015-09-30 | $-40 |
| 2015-06-30 | $-1 |
| 2015-03-31 | $-10 |
| 2014-12-31 | $4 |
| 2014-09-30 | $-3 |
| 2014-06-30 | $-4 |
| 2014-03-31 | $-10 |
| 2013-12-31 | $0 |
| 2013-09-30 | $-4 |
| 2013-06-30 | $-8 |
| 2013-03-31 | $-9 |
| 2012-12-31 | $-6 |
| 2012-09-30 | $-15 |
| 2012-06-30 | $-13 |
| 2012-03-31 | $-14 |
| 2011-12-31 | $-11 |
| 2011-09-30 | $-12 |
| 2011-06-30 | $-6 |
| 2011-03-31 | $-11 |
| 2010-12-31 | $-9 |
| 2010-09-30 | $-12 |
| 2010-06-30 | $-10 |
| 2010-03-31 | $-10 |
| 2009-12-31 | $-9 |
| 2009-09-30 | $-11 |
| 2009-06-30 | $-12 |
| 2009-03-31 | $-10 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $29.443B | $4.033B |
| DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of DexCom's monitoring system technology is the continuous measure of patient's blood glucose level and transmission of that information to a small cell phone-sized receiver in real time. The company's monitoring systems aim to provide real-time continuous blood glucose values, trend data and alerts to assist patients in managing their blood glucose levels. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $184.932B | 22.37 |
| Intuitive Surgical (ISRG) | United States | $169.861B | 70.41 |
| IDEXX Laboratories (IDXX) | United States | $51.765B | 53.87 |
| Edwards Lifesciences (EW) | United States | $47.690B | 31.61 |
| Alcon (ALC) | Switzerland | $39.183B | 26.31 |
| IQVIA Holdings (IQV) | United States | $32.084B | 18.13 |
| Mettler-Toledo (MTD) | United States | $26.431B | 31.37 |
| STERIS (STE) | Ireland | $24.108B | 25.66 |
| Waters (WAT) | United States | $17.717B | 24.34 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.161B | 0.00 |
| Hologic (HOLX) | United States | $14.818B | 16.05 |
| Penumbra (PEN) | United States | $10.595B | 77.40 |
| Globus Medical (GMED) | United States | $8.256B | 19.04 |
| Sysmex ADR (SSMXY) | Japan | $8.070B | 25.64 |
| Masimo (MASI) | United States | $7.657B | 25.77 |
| Teleflex (TFX) | United States | $5.578B | 9.00 |
| Glaukos (GKOS) | United States | $5.538B | 0.00 |
| TransMedics (TMDX) | United States | $3.979B | 60.48 |
| Integer Holdings (ITGR) | United States | $3.762B | 18.77 |
| LivaNova (LIVN) | United Kingdom | $3.028B | 17.33 |
| Alphatec Holdings (ATEC) | United States | $2.372B | 0.00 |
| Veracyte (VCYT) | United States | $2.356B | 32.55 |
| PROCEPT BioRobotics (PRCT) | United States | $2.244B | 0.00 |
| Artivion (AORT) | United States | $2.067B | 104.31 |
| Nihon Kohden (NHNKY) | Japan | $1.940B | 23.16 |
| Elekta AB (EKTAY) | Sweden | $1.806B | 17.50 |
| Integra LifeSciences Holdings (IART) | United States | $1.156B | 6.62 |
| OPKO Health (OPK) | United States | $1.127B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.047B | 0.00 |
| IRadimed (IRMD) | United States | $0.929B | 45.07 |
| Beta Bionics (BBNX) | United States | $0.813B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $0.797B | 0.00 |
| AxoGen (AXGN) | United States | $0.746B | 0.00 |
| SiBone (SIBN) | United States | $0.717B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.582B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.551B | 9.73 |
| OrthoPediatrics (KIDS) | United States | $0.538B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.467B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.453B | 3.64 |
| AngioDynamics (ANGO) | United States | $0.412B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.399B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.381B | 90.67 |
| RxSight (RXST) | United States | $0.374B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.371B | 9.43 |
| Spectral Diagnostics (EDTXF) | Canada | $0.305B | 0.00 |
| NeuroPace (NPCE) | United States | $0.301B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.298B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.294B | 20.26 |
| Alpha Tau Medical (DRTS) | Israel | $0.285B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.235B | 0.00 |
| Neuronetics (STIM) | United States | $0.227B | 0.00 |
| 908 Devices (MASS) | United States | $0.224B | 0.00 |
| Inogen (INGN) | United States | $0.215B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.212B | 0.00 |
| CVRx (CVRX) | United States | $0.206B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.182B | 0.00 |
| Accuray (ARAY) | United States | $0.176B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.155B | 0.00 |
| LENSAR (LNSR) | United States | $0.145B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.130B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.130B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.111B | 0.00 |
| InspireMD (NSPR) | United States | $0.101B | 0.00 |
| Hyperfine (HYPR) | United States | $0.097B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.097B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.083B | 0.00 | |
| QT Imaging Holdings (QTIH) | United States | $0.070B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.068B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.054B | 0.00 |
| Spectral AI (MDAI) | United States | $0.053B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.045B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.038B | 0.00 |
| Precision Optics (POCI) | United States | $0.038B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.026B | 0.00 |
| Envoy Medical (COCH) | United States | $0.026B | 0.00 |
| DarioHealth (DRIO) | United States | $0.023B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.017B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.015B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.012B | 0.00 |
| Tenon Medical (TNON) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.007B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.007B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 13.30 |